BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34964678)

  • 1. Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs.
    Spolverato G; Glavas D; Hewitt DB; Brown ZJ; Capelli G; Bergamo F; Rizzato MD; Pawlik TM
    Expert Opin Pharmacother; 2022 Mar; 23(4):473-481. PubMed ID: 34964678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies.
    Schweitzer N; Vogel A
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):345-53. PubMed ID: 25966433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A; Maréchal R; Devière J; Van Laethem JL
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiocellular Carcinoma.
    Vogel A; Saborowski A
    Digestion; 2017; 95(3):181-185. PubMed ID: 28288474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis and treatment of cholangiocarcinoma.
    Vogel A; Wege H; Caca K; Nashan B; Neumann U
    Dtsch Arztebl Int; 2014 Oct; 111(44):748-54. PubMed ID: 25412632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in targeted therapy of cholangiocarcinoma.
    Li Y; Yu J; Zhang Y; Peng C; Song Y; Liu S
    Ann Med; 2024 Dec; 56(1):2310196. PubMed ID: 38359439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Standards, Multidisciplinary Approaches, and Future Directions in the Management of Extrahepatic Cholangiocarcinoma.
    Wheless M; Agarwal R; Goff L; Lockney N; Padmanabhan C; Heumann T
    Curr Treat Options Oncol; 2024 Jan; 25(1):127-160. PubMed ID: 38177560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future directions in the treatment of cholangiocarcinoma.
    Zhu AX
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):355-61. PubMed ID: 25966434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular targeted and systemic therapy for intrahepatic cholangiocarcinoma: a multi-disciplinary approach.
    Merath K; Tiwari A; Parikh AA; Pawlik TM
    Future Oncol; 2023 Dec; 19(39):2607-2621. PubMed ID: 38108100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholangiocarcinoma: principles and current trends.
    Zografos GN; Farfaras A; Zagouri F; Chrysikos D; Karaliotas K
    Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):10-20. PubMed ID: 21269929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical management of cholangiocarcinomas in 2015].
    Marret G; Neuzillet C; Rousseau B; Tournigand C
    Bull Cancer; 2016 Apr; 103(4):389-99. PubMed ID: 26922666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma.
    Massironi S; Pilla L; Elvevi A; Longarini R; Rossi RE; Bidoli P; Invernizzi P
    Cells; 2020 Mar; 9(3):. PubMed ID: 32168869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updates in the use of targeted therapies for the treatment of cholangiocarcinoma.
    Lodl E; Ramnaraign B; Sahin I; Wheeler S
    J Oncol Pharm Pract; 2023 Jul; 29(5):1206-1217. PubMed ID: 37097888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of perioperative chemotherapy on survival in patients with cholangiocarcinoma undergoing curative resection.
    Hassan H; Chakrabarti S; Zemla T; Yin J; Wookey V; Prasai K; Abdellatief A; Katta R; Tran N; Jin Z; Cleary S; Roberts L; Mahipal A
    Eur J Surg Oncol; 2023 Nov; 49(11):106994. PubMed ID: 37524649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in research and application of photodynamic therapy in cholangiocarcinoma (Review).
    Li Y; Li Y; Song Y; Liu S
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38334150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narrative review: current management and novel targeted therapies in intrahepatic cholangiocarcinoma.
    Bath NM; Pawlik TM
    Chin Clin Oncol; 2023 Feb; 12(1):5. PubMed ID: 36922354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and emerging targets for cholangiocarcinoma progression: therapeutic implications.
    Kankeu Fonkoua LA; Serrano Uson Junior PL; Mody K; Mahipal A; Borad MJ; Roberts LR
    Expert Opin Ther Targets; 2022 Jan; 26(1):79-92. PubMed ID: 35034558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant lesions of the extrahepatic biliary system].
    Litchinko A; Peloso A; Toso C; Compagnon P
    Rev Med Suisse; 2022 Jun; 18(786):1210-1217. PubMed ID: 35703864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proximal biliary tumors.
    Brown KM; Geller DA
    Surg Clin North Am; 2014 Apr; 94(2):311-23. PubMed ID: 24679423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of cholangiocarcinoma.
    Jarnagin WR; Shoup M
    Semin Liver Dis; 2004 May; 24(2):189-99. PubMed ID: 15192791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.